Literature DB >> 12650964

Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea.

Ian S Zagon1, Torre B Ruth, Alphonse E Leure-duPree, Joseph W Sassani, Patricia J McLaughlin.   

Abstract

This study was conducted to determine the cellular and subcellular location(s) of the opioid growth factor receptor (OGFr), and the opioid growth factor (OGF), [Met(5)]-enkephalin, in the corneal epithelium. Laser scanning confocal microscopy analysis revealed that both OGFr and OGF were colocalized in the paranuclear cytoplasm and cell nuclei in basal, as well as suprabasal, cells of adult rat corneal epithelium. Using a postembedding immunogold procedure for immunoelectron microscopy that included embedding in Unicryl, both single- and double-face labeling studies were performed. Immunogold labeling of OGFr was detected on the outer nuclear envelope, in the paranuclear cytoplasm proximal to the nuclear envelope, perpendicular to the nuclear envelope in a putative nuclear pore complex, and within the nucleus adjacent to heterochromatin. Immunoreactivity for OGF was noted in locations similar to that for OGFr. In addition, aggregates of staining for OGF were found throughout the cytoplasm, including subjacent to the plasma membrane. Double labeling experiments revealed that complexes of OGF-OGFr were colocalized on the outer nuclear envelope, in the paranuclear cytoplasm, extending across the nuclear pore complex, and in the nucleus. Anti-OGFr IgG by itself, but not anti-OGF IgG alone, was associated with the outer nuclear envelope, and uncomplexed OGF immunoreactivity was detected in the cytoplasm in dual labeling experiments. These results based on complementary approaches of confocal microscopy and immunoelectron microscopy, suggest that: (i) OGFr resides on the outer nuclear envelope, (ii) OGF interacts with OGFr at the outer nuclear envelope, (iii) the colocalized receptor and peptide translocates between the cytoplasm and the nucleus at the nuclear pore, and (iv) signal transduction for modulation of cell proliferation necessitates a peptide-receptor complex that interfaces with chromatin in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650964     DOI: 10.1016/s0006-8993(02)04172-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

2.  Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer.

Authors:  Jill P Smith; Sandra I Bingaman; David T Mauger; Harold H Harvey; Laurence M Demers; Ian S Zagon
Journal:  Open Access J Clin Trials       Date:  2010-03-01

3.  Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent.

Authors:  Nancy P Kren; Ian S Zagon; Patricia J McLaughlin
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-30

Review 4.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

Review 5.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

Review 6.  Recent developments in multiplexing techniques for immunohistochemistry.

Authors:  Angela R Dixon; Cédric Bathany; Michael Tsuei; Joshua White; Kate F Barald; Shuichi Takayama
Journal:  Expert Rev Mol Diagn       Date:  2015-08-06       Impact factor: 5.225

7.  The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.

Authors:  Diego M Avella; Eric T Kimchi; Renee N Donahue; Hephzibah Rani S Tagaram; Patricia J McLaughlin; Ian S Zagon; Kevin F Staveley-O'Carroll
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

8.  The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

9.  Integrated Proteomic and Transcriptomic Analysis Reveals Long Noncoding RNA HOX Transcript Antisense Intergenic RNA (HOTAIR) Promotes Hepatocellular Carcinoma Cell Proliferation by Regulating Opioid Growth Factor Receptor (OGFr).

Authors:  Ying Wu; Qian Xiong; Siting Li; Xue Yang; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2017-10-27       Impact factor: 5.911

Review 10.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.